ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

LNSR LENSAR Inc

4.065
0.035 (0.87%)
May 21 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 10,209
Bid Price 3.56
Ask Price 9.62
News -
Day High 4.10

Low
1.80

52 Week Range

High
5.30

Day Low 3.78
Share Name Share Symbol Market Stock Type
LENSAR Inc LNSR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.035 0.87% 4.065 23:00:00
Open Price Low Price High Price Close Price Previous Close
4.10 3.78 4.10 4.065 4.03
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
110 10,209 US$ 3.98 US$ 40,614 - 1.80 - 5.30
Last Trade Type Quantity Price Currency
15:00:00 73 US$ 3.97 USD

LENSAR Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
46.26M 11.40M - 42.16M -14.38M -1.26 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

LENSAR News

Date Time Source News Article
5/13/202415:00Edgar (US Regulatory)Form 8-K - Current report
5/09/202415:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202406:30Edgar (US Regulatory)Form 8-K - Current report
5/09/202406:00Business WireLENSAR Reports First Quarter 2024 Results and Provides..
5/08/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/08/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/08/202415:00Edgar (US Regulatory)Form 8-K - Current report
5/02/202407:00Business WireLENSAR to Report First Quarter 2024 Financial Results on..
5/01/202417:38Business WireLENSAR Reports Inducement Grants Under Nasdaq Listing Rule..
4/01/202417:28Business WireLENSAR Reports Inducement Grants Under Nasdaq Listing Rule..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No LNSR Message Board. Create One! See More Posts on LNSR Message Board See More Message Board Posts

Historical LNSR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.854.353.62674.1226,0780.2155.58%
1 Month3.204.352.9513.4838,7800.86527.03%
3 Months4.775.302.673.6644,968-0.705-14.78%
6 Months2.105.302.103.5539,4731.9793.57%
1 Year2.405.301.803.4931,9281.6769.38%
3 Years7.918.981.804.7821,913-3.85-48.61%
5 Years3.1612.711.806.1728,4610.90528.64%

LENSAR Description

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.